Therapeutic approaches beyond positive airway pressure and bronchodilators: time for rehabilitation? Source: Sleep and Breathing Conference 2021 Year: 2021
Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
Acute bronchodilator responsiveness in a global respiratory trial (UPLIFT) following maximal inhaled bronchodilators Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
Time to maximal response to bronchodilators in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 281s Year: 2006
Switching to maintenance and reliever inhaled corticosteroid/long acting beta agonist: a real-world pilot evaluation in a regional paediatric difficult asthma clinic. Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020
First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Is it time to move away from short-acting beta-agonists in asthma management? Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018 Year: 2019
The future of bronchodilation: looking for new classes of bronchodilators Source: Eur Respir Rev, 28 (154) 190095; 10.1183/16000617.0095-2019 Year: 2019
Once per day inhaled corticosteroids: a method to improve compliance and asthma control Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001
Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020
The concept study: comparative influence of two treatment strategies on airway response to AMP Source: Annual Congress 2005 - Combination therapy for asthma. Which, why and how? Year: 2005
The inhaled corticosteroids questionnaire shortened version (ICQ-S): A brief patient-rated scale for monitoring inhaled corticosteroid side effects in clinical practice Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010
Is compliance with ICS treatment increased when a MDI canister with audible and visual reminder functions is used? Source: Eur Respir J 2006; 28: Suppl. 50, 57s Year: 2006
Individual and differential treatment responses to once-daily long acting bronchodilators, glycopirronium and indacaterol, and combination of both drugs in the patients with moderate or severe COPD Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Treatment with inhaled corticosteroids (ICS) and long acting b2-agonists (LABA) combination in patients with COPD: Possible way of optimization Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011